Compare TBPH & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | MOMO |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2013 | 2014 |
| Metric | TBPH | MOMO |
|---|---|---|
| Price | $19.26 | $6.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $27.80 | $13.00 |
| AVG Volume (30 Days) | 386.5K | ★ 662.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.53% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $70.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.66 | ★ $10.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.90 | $5.13 |
| 52 Week High | $21.03 | $9.22 |
| Indicator | TBPH | MOMO |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 43.40 |
| Support Level | $18.27 | $6.39 |
| Resistance Level | $19.04 | $7.14 |
| Average True Range (ATR) | 0.91 | 0.15 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 23.72 | 33.66 |
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.